Park SW, Casalena DE, Wilson DJ, et al. Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis. Chem Biol. 2015;22(1):76-86. doi:10.1016/j.chembiol.2014.11.012.
Yu H, Chen JK, Feng S, Dalgarno DC, Brauer AW, Schreiber SL. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 1994;76(5):933-45.
Wawer M, Bajorath J. Extraction of structure-activity relationship information from high-throughput screening data. Curr Med Chem. 2009;16(31):4049-57.
Zhang W, Lun S, Wang S-H, et al. Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. J Med Chem. 2018;61(3):791-803. doi:10.1021/acs.jmedchem.7b01319.
Yang J, Shamji A, Matchacheep S, Schreiber SL. Identification of a small-molecule inhibitor of class Ia PI3Ks with cell-based screening. Chem Biol. 2007;14(4):371-7. doi:10.1016/j.chembiol.2007.02.004.
Shaw SY, Tran K, Castoreno AB, et al. Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. ACS Chem Biol. 2013;8(12):2724-33. doi:10.1021/cb400352d.
Tallarico JA, Depew KM, Pelish HE, et al. An alkylsilyl-tethered, high-capacity solid support amenable to diversity-oriented synthesis for one-bead, one-stock solution chemical genetics. J Comb Chem. 2001;3(3):312-8.
Wawer M, Bajorath J. Systematic extraction of structure-activity relationship information from biological screening data. ChemMedChem. 2009;4(9):1431-8. doi:10.1002/cmdc.200900222.